Nazakat L, Ali S, Summer M, Nazakat F, Noor S, Riaz A
Inflammopharmacology. 2025; .
PMID: 40074996
DOI: 10.1007/s10787-025-01664-7.
Chan E, Mani A
Physiol Rep. 2025; 13(3):e70230.
PMID: 39903575
PMC: 11793006.
DOI: 10.14814/phy2.70230.
Khodadust F, Philippon E, Steinz M, van Hamburg J, Van Meerloo J, van Beijnum J
Cells. 2025; 14(2).
PMID: 39851530
PMC: 11764070.
DOI: 10.3390/cells14020102.
Bencze F, Kiss L, Li H, Yan H, Kollar L, Kunsagi-Mate S
Int J Mol Sci. 2024; 25(23).
PMID: 39684413
PMC: 11641236.
DOI: 10.3390/ijms252312703.
Martinez de la Torre A, Clausen A, Burden A, Weiler S
Drug Saf. 2024; 48(2):191-201.
PMID: 39604587
PMC: 11785614.
DOI: 10.1007/s40264-024-01490-w.
Unlocking the Future: New Biologic Therapies for Rheumatoid Arthritis.
Patil S, Thorat V, Koparde A, Bhinge S, Chavan D, Bhosale R
Cureus. 2024; 16(10):e72486.
PMID: 39600762
PMC: 11592031.
DOI: 10.7759/cureus.72486.
Dabigatran attenuates methotrexate-induced hepatotoxicity by regulating coagulation, endothelial dysfunction, and the NF-kB/IL-1β/MCP-1 and TLR4/NLRP3 signaling pathways.
El-Dessouki A, Alzokaky A, Raslan N, Ibrahim S, Selim H, Al-Karmalawy A
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39527308
DOI: 10.1007/s00210-024-03567-w.
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.
Buch M, Aletaha D, Combe B, Tanaka Y, Caporali R, Schulze-Koops H
RMD Open. 2024; 10(4).
PMID: 39455065
PMC: 11529685.
DOI: 10.1136/rmdopen-2024-004476.
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?.
Taylor P, Feist E, Pope J, Nash P, Sibilia J, Caporali R
Ther Adv Musculoskelet Dis. 2024; 16:1759720X241283340.
PMID: 39444594
PMC: 11497505.
DOI: 10.1177/1759720X241283340.
Navel orange peel ethanolic extract and naringin ameliorate CFA-induced arthritis in Wistar rats through their modulatory effects on Th1/Th2/Th17 cytokines and oxidative stress.
Ahmed O, Ahmed R, Abdel-Hafeez D, Ahmed R, Mallasiy L, El-Gawaad N
Am J Transl Res. 2024; 16(9):4696-4713.
PMID: 39398602
PMC: 11470294.
DOI: 10.62347/OEHX5202.
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, Fumery M, Bernardeau C
Drugs Real World Outcomes. 2024; 11(4):573-591.
PMID: 39384685
PMC: 11589083.
DOI: 10.1007/s40801-024-00459-6.
IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis.
Swarnkar G, Naaz M, Mims D, Gupta P, Peterson T, Christopher M
Arthritis Rheumatol. 2024; 77(2):124-139.
PMID: 39279148
PMC: 11785494.
DOI: 10.1002/art.42990.
Effects of a telehealth-delivered Mediterranean diet intervention in adults with Rheumatoid Arthritis (MEDRA): a randomised controlled trial.
Raad T, George E, Griffin A, Larkin L, Fraser A, Kennedy N
BMC Musculoskelet Disord. 2024; 25(1):631.
PMID: 39112976
PMC: 11308202.
DOI: 10.1186/s12891-024-07742-1.
Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis.
Ouranos K, Avila D, Mylona E, Vassilopoulos A, Vassilopoulos S, Shehadeh F
PLoS One. 2024; 19(7):e0306548.
PMID: 39083492
PMC: 11290652.
DOI: 10.1371/journal.pone.0306548.
Application of 3D bioprinting technology apply to assessing Dangguiniantongtang (DGNT) decoctions in arthritis.
Liang Z, Han Y, Chen T, Wang J, Lin K, Yuan L
Chin Med. 2024; 19(1):96.
PMID: 38978120
PMC: 11229348.
DOI: 10.1186/s13020-024-00948-4.
Computational discovery of AKT serine/threonine kinase 1 inhibitors through shape screening for rheumatoid arthritis intervention.
Rangaswamy R, Sneha S, Hemavathy N, Umashankar V, Jeyakanthan J
Mol Divers. 2024; 29(2):1287-1303.
PMID: 38970640
DOI: 10.1007/s11030-024-10910-z.
A new class of 7-deazaguanine agents targeting autoimmune diseases: dramatic reduction of synovial fibroblast IL-6 production from human rheumatoid arthritis patients and improved performance against murine experimental autoimmune encephalomyelitis.
Cotter M, Quinn S, Fearon U, Ansboro S, Rakovic T, Southern J
RSC Med Chem. 2024; 15(5):1556-1564.
PMID: 38784475
PMC: 11110761.
DOI: 10.1039/d4md00028e.
PTEN: an emerging target in rheumatoid arthritis?.
Zhou P, Meng X, Nie Z, Wang H, Wang K, Du A
Cell Commun Signal. 2024; 22(1):246.
PMID: 38671436
PMC: 11046879.
DOI: 10.1186/s12964-024-01618-6.
Deciphering the relationship between temperature and immunity.
Maloney E, Duffy D
Discov Immunol. 2024; 3(1):kyae001.
PMID: 38567294
PMC: 10917241.
DOI: 10.1093/discim/kyae001.
Impact of filgotinib on pain control in the phase 3 FINCH studies.
Taylor P, Kavanaugh A, Nash P, Pope J, Pongratz G, Fautrel B
RMD Open. 2024; 10(1).
PMID: 38479751
PMC: 10936501.
DOI: 10.1136/rmdopen-2023-003839.